MHLW to Carefully Discuss Cost Effectiveness of Prevenar 13 for Its Elderly Use under National Program

December 18, 2015
A vaccine evaluation panel of the health ministry agreed on December 17 to carefully discuss whether to add Pfizer’s Prevenar 13, a pneumococcal 13-valent conjugate vaccine, to the publicly funded immunization program for use in the elderly by estimating its...read more